American Express enters its July 24 earnings report with analyst sentiment shifting higher, even as the stock drifts modestly lower on the week and the underlying business debate remains very much alive.
The Street's direction has turned more bullish in recent weeks. Truist Securities raised its target to $375 from $360 on June 24 while keeping a Buy rating — the latest in a string of upgrades following the Q1 print. Goldman Sachs had already moved to $400 back in late April, also reiterating Buy. BofA is at $387 with a Buy. Loop Capital initiated at $389 with a Buy in late May. The outlier is BTIG, which has reiterated Sell with a $285 target twice in the past two months — a meaningful 16% below current levels. The mean consensus target across the covering analysts is $363, implying modest upside from the current $337.78. Barclays and Morgan Stanley sit in the middle, both at Equal-Weight with targets in the low-to-mid $300s — broadly in line with where the stock is trading, not above it.
The bull-bear debate has a clear structure. Bulls point to new account growth in both Consumer and Commercial segments as a durable offset to softening same-customer spend, plus a dividend factor score ranking in the 94th percentile relative to the broader universe. Bears counter that New Card Acquisition declined both sequentially and year-over-year in Q1, that the Platinum Card relaunch has yet to reverse the underlying trend, and that private credit headwinds could weigh on the spending behaviour of AXP's super-prime base. The trailing PE has expanded to roughly 18x and price-to-book is near 6x — up about 7% and 7% respectively over the past 30 days as the stock rallied 8.3% in June, leaving some sceptics questioning whether the valuation already prices a recovery in card acquisition. The EPS surprise factor sits at the 71st percentile, a genuine strength, while forward EPS momentum at the 30-day and 90-day horizons is more tepid at 59 and 49 respectively.
Short positioning adds little tension to the setup. At 1.8% of the free float, short interest is low by any measure. It has drifted up about 7% over the past week — from roughly 11.7 million shares to 12.6 million — but that follows a sharper drop in May when shorts trimmed aggressively from a recent high near 13.8 million shares. Borrowing costs remain negligible at 0.48%, even after a 44% weekly jump that looks more like noise than conviction. Availability in the lending market is extremely loose at nearly 4,849% — meaning there are roughly 49 shares available to borrow for every one already lent out. The ORTEX short score of 35.5 has crept higher over the past two weeks but remains well below any level that would suggest meaningful short pressure building. Options positioning is equally calm: the put/call ratio of 0.59 is virtually flat to its 20-day average of 0.585, with a z-score close to zero. Neither options traders nor short sellers appear to be bracing for a negative catalyst.
The ownership picture is anchored by Berkshire Hathaway, which holds 22.2% of shares and has not adjusted its position in the most recent reported period. Berkshire's stability at the top of the register is a structural feature of AXP's shareholder base rather than a near-term signal, but it does limit the float meaningfully. Among other large holders, PIMCO added 6.4 million shares in Q1 — a notable build for a fixed-income-oriented manager — while UBS Asset Management added 1.8 million. On the insider side, Chief Level Officer Glenda McNeal sold 7,033 shares for roughly $2.4 million on June 15. The transaction significance score is modest at 3 out of 10, and insider activity more broadly has skewed toward routine selling at elevated prices rather than any directional signal.
AXP's last earnings print on April 23 saw the stock fall 5.7% on the day and a further 3% over the following week — the setup heading into the July 24 report is therefore less about whether the borrow market or options flow are flashing warnings, and more about whether new card acquisition data in Q2 shows any recovery from the Q1 weakness that rattled the Street.
See the live data behind this article on ORTEX.
Open AXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
